| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 | 
| NetGPI | no | yes: 0, no: 10 | 
Related structures:
AlphaFold database: A4IBQ3
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 164 | 168 | PF00656 | 0.771 | 
| CLV_C14_Caspase3-7 | 6 | 10 | PF00656 | 0.486 | 
| CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.535 | 
| CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.684 | 
| CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.491 | 
| CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.559 | 
| CLV_PCSK_KEX2_1 | 197 | 199 | PF00082 | 0.692 | 
| CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.491 | 
| CLV_PCSK_PC7_1 | 3 | 9 | PF00082 | 0.500 | 
| DOC_PP2B_LxvP_1 | 113 | 116 | PF13499 | 0.580 | 
| DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.549 | 
| DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.663 | 
| DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.628 | 
| LIG_14-3-3_CanoR_1 | 153 | 162 | PF00244 | 0.746 | 
| LIG_14-3-3_CanoR_1 | 18 | 23 | PF00244 | 0.512 | 
| LIG_14-3-3_CanoR_1 | 25 | 30 | PF00244 | 0.595 | 
| LIG_14-3-3_CanoR_1 | 38 | 47 | PF00244 | 0.415 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.672 | 
| LIG_EH1_1 | 16 | 24 | PF00400 | 0.497 | 
| LIG_eIF4E_1 | 17 | 23 | PF01652 | 0.515 | 
| LIG_FHA_1 | 39 | 45 | PF00498 | 0.445 | 
| LIG_LIR_Gen_1 | 45 | 55 | PF02991 | 0.639 | 
| LIG_PTAP_UEV_1 | 143 | 148 | PF05743 | 0.642 | 
| LIG_SH3_3 | 141 | 147 | PF00018 | 0.698 | 
| LIG_SUMO_SIM_anti_2 | 169 | 179 | PF11976 | 0.696 | 
| LIG_SUMO_SIM_anti_2 | 75 | 82 | PF11976 | 0.527 | 
| LIG_SUMO_SIM_par_1 | 105 | 111 | PF11976 | 0.501 | 
| LIG_SUMO_SIM_par_1 | 134 | 140 | PF11976 | 0.455 | 
| LIG_TRAF2_1 | 119 | 122 | PF00917 | 0.654 | 
| MOD_CK1_1 | 140 | 146 | PF00069 | 0.592 | 
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.658 | 
| MOD_CK1_1 | 68 | 74 | PF00069 | 0.782 | 
| MOD_CK2_1 | 69 | 75 | PF00069 | 0.708 | 
| MOD_GlcNHglycan | 103 | 107 | PF01048 | 0.631 | 
| MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.632 | 
| MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.669 | 
| MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.522 | 
| MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.735 | 
| MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.739 | 
| MOD_GSK3_1 | 102 | 109 | PF00069 | 0.529 | 
| MOD_GSK3_1 | 33 | 40 | PF00069 | 0.640 | 
| MOD_GSK3_1 | 65 | 72 | PF00069 | 0.740 | 
| MOD_NEK2_1 | 37 | 42 | PF00069 | 0.610 | 
| MOD_NEK2_1 | 86 | 91 | PF00069 | 0.559 | 
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.686 | 
| MOD_PKA_2 | 37 | 43 | PF00069 | 0.589 | 
| MOD_Plk_1 | 75 | 81 | PF00069 | 0.696 | 
| MOD_Plk_2-3 | 186 | 192 | PF00069 | 0.715 | 
| MOD_Plk_2-3 | 75 | 81 | PF00069 | 0.703 | 
| MOD_Plk_4 | 18 | 24 | PF00069 | 0.482 | 
| MOD_Plk_4 | 75 | 81 | PF00069 | 0.685 | 
| MOD_Plk_4 | 86 | 92 | PF00069 | 0.512 | 
| MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.634 | 
| TRG_DiLeu_BaEn_1 | 75 | 80 | PF01217 | 0.534 | 
| TRG_ER_diArg_1 | 197 | 199 | PF00400 | 0.692 | 
| TRG_Pf-PMV_PEXEL_1 | 198 | 202 | PF00026 | 0.715 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1PBI1 | Leptomonas seymouri | 45% | 92% | 
| A0A1X0P5H7 | Trypanosomatidae | 34% | 100% | 
| A0A3Q8IMQ4 | Leishmania donovani | 99% | 100% | 
| A0A422NR35 | Trypanosoma rangeli | 37% | 100% | 
| A4HN35 | Leishmania braziliensis | 71% | 99% | 
| C9ZYX2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 81% | 
| E9AFI8 | Leishmania major | 89% | 99% | 
| E9B6P3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 99% | 
| V5BD49 | Trypanosoma cruzi | 35% | 100% |